Abstract 4365360: Trends in Mortality Involving Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease Among Adults in the United States, A 25-Year National Mortality Analysis (1999-2023)

Introduction: Pulmonary hypertension (PH), a progressive and life-threatening disorder, is often associated with chronic obstructive pulmonary disease (COPD). This combination worsens prognosis, increases healthcare burden through hospitalizations, and raises mortality risk. Despite its impact, PH-related mortality trends in COPD patients have not been assessed in the U.S. over two decades. Aim: To investigate trends and demographic patterns of COPD-associated PH deaths among U.S. adults ≥ 25 years from 1999–2023. Methods: CDC WONDER multiple-cause-of-death data (1999–2023) for decedents ≥ 25 years listing PH (ICD-10: I27) and COPD (J40–J44) were used. Crude and age-adjusted mortality rates (AAMR) per 100,000 were computed using the 2000 U.S. standard population. Joinpoint Regression v5.2.0 calculated annual percent changes (APC) with 95% confidence intervals (CIs; p ≤ 0.05), stratified by year, sex, race/ethnicity, region, urbanization, and age. Results: Between 1999 and 2023, 162,517 COPD-associated PH deaths occurred. Overall, AAMR declined from 2.7 in 1999 to 2.2 in 2001 (APC: –12.41; 95% CI: –21.91 to –1.76), surged to 3.0 by 2004 (APC: 12.15), plateaued until 2015 (APC: 0.04), then rose to 3.5 in 2023 (APC: 2.44; 95% CI: 1.49 to 3.40). Among women, AAMRs declined initially (1999–2001; APC: –12.78), rebounded to 3.0 by 2004 (APC: 16.43), climbed modestly to 2015 (APC: 0.50), and increased further from 2015 to 2023 (APC: 2.97). In contrast, men had a continuous upward trend over the entire period (APC: 0.39). Non-Hispanic Whites had the highest AAMR (3.22), followed by Non-Hispanic Blacks (3.05), Non-Hispanic American Indians (2.50), Hispanics (1.08), and Non-Hispanic Asians (0.91). Regionally, the Midwest recorded the highest AAMR (3.5); rural areas exceeded urban areas (3.4 vs 2.8). At the state level, Colorado had the highest AAMR (6.7), while Louisiana had the lowest (1.4). Age-stratified analysis showed that individuals ≥ 85 years experienced the highest rates over time (AAPC: 3.64; 95% CI: 0.60–6.55). Conclusion: COPD-associated PH mortality initially declined and then rose, particularly among women, American Indians, Hispanics, Southern and rural residents, and adults aged 55–64 and ≥ 75. These findings highlight the urgent need to address underlying demographic and geographic disparities.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-03
DOI
https://doi.org/10.1161/circ.152.suppl_3.4365360
Primary Topic
Cardiovascular Health and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4365360: Trends in Mortality Involving Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease Among Adults in the United States, A 25-Year National Mortality Analysis (1999-2023)

Muhammad Ali Ehsan, Syeda Rizvi, Bernardo Cortese, Adeena Azam et al.
Circulation
Cardiovascular Health and Risk Factors
article

Abstract 4365360: Trends in Mortality Involving Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease Among Adults in the United States, A 25-Year National Mortality Analysis (1999-2023)

Muhammad Ali Ehsan, Syeda Rizvi, Bernardo Cortese, Adeena Azam, Adil Ahmed, Muhammad Wajeeh Ul Hassan, Javeria Javeid, Areej Javeid, FNU Kalpina, Laiba Javed
article en

Abstract

Introduction: Pulmonary hypertension (PH), a progressive and life-threatening disorder, is often associated with chronic obstructive pulmonary disease (COPD). This combination worsens prognosis, increases healthcare burden through hospitalizations, and raises mortality risk. Despite its impact, PH-related mortality trends in COPD patients have not been assessed in the U.S. over two decades. Aim: To investigate trends and demographic patterns of COPD-associated PH deaths among U.S. adults ≥ 25 years from 1999–2023. Methods: CDC WONDER multiple-cause-of-death data (1999–2023) for decedents ≥ 25 years listing PH (ICD-10: I27) and COPD (J40–J44) were used. Crude and age-adjusted mortality rates (AAMR) per 100,000 were computed using the 2000 U.S. standard population. Joinpoint Regression v5.2.0 calculated annual percent changes (APC) with 95% confidence intervals (CIs; p ≤ 0.05), stratified by year, sex, race/ethnicity, region, urbanization, and age. Results: Between 1999 and 2023, 162,517 COPD-associated PH deaths occurred. Overall, AAMR declined from 2.7 in 1999 to 2.2 in 2001 (APC: –12.41; 95% CI: –21.91 to –1.76), surged to 3.0 by 2004 (APC: 12.15), plateaued until 2015 (APC: 0.04), then rose to 3.5 in 2023 (APC: 2.44; 95% CI: 1.49 to 3.40). Among women, AAMRs declined initially (1999–2001; APC: –12.78), rebounded to 3.0 by 2004 (APC: 16.43), climbed modestly to 2015 (APC: 0.50), and increased further from 2015 to 2023 (APC: 2.97). In contrast, men had a continuous upward trend over the entire period (APC: 0.39). Non-Hispanic Whites had the highest AAMR (3.22), followed by Non-Hispanic Blacks (3.05), Non-Hispanic American Indians (2.50), Hispanics (1.08), and Non-Hispanic Asians (0.91). Regionally, the Midwest recorded the highest AAMR (3.5); rural areas exceeded urban areas (3.4 vs 2.8). At the state level, Colorado had the highest AAMR (6.7), while Louisiana had the lowest (1.4). Age-stratified analysis showed that individuals ≥ 85 years experienced the highest rates over time (AAPC: 3.64; 95% CI: 0.60–6.55). Conclusion: COPD-associated PH mortality initially declined and then rose, particularly among women, American Indians, Hispanics, Southern and rural residents, and adults aged 55–64 and ≥ 75. These findings highlight the urgent need to address underlying demographic and geographic disparities.

CirculationVol. 152(Suppl_3)
Cleveland Clinic (US), Allama Iqbal Medical College (PK), University Hospitals of Cleveland (US), Dow University of Health Sciences (PK), Northwest General Hospital and Research Center (PK)
Openalex Percentile: Top 52%
Cardiovascular Health and Risk Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.